| Bioactivity | CSTSMLKAC (peptide 2) is a cyclic 9 amino acid sequence that mimics endogenous peptide sequences. CSTSMLKAC homes to cardiomyocytes in the ischemic myocardium[1]. |
| Name | CSTSMLKAC (disulfide) |
| Sequence | Cys-Ser-Thr-Ser-Met-Leu-Lys-Ala-Cys (Disulfide bridge: Cys1-Cys9) |
| Shortening | CSTSMLKAC (Disulfide bridge: Cys1-Cys9) |
| Formula | C36H64N10O13S3 |
| Molar Mass | 941.15 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Mónica P A Ferreira, et al. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles. Biomaterials. 2016, 93, 104. |
CSTSMLKAC (disulfide)
CAS: F: C36H64N10O13S3 W: 941.15
CSTSMLKAC (peptide 2) is a cyclic 9 amino acid sequence that mimics endogenous peptide sequences. CSTSMLKAC homes to car
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.